Palatability of oral antibiotic suspensions is important and may be a
substantial factor in determining compliance in young pediatric patien
ts. Because no comparative systematic data are available, we undertook
the present study to assess the acceptance of and compliance with ora
l antibiotic suspensions commonly used in Israel. During a 4-month per
iod lists of children receiving oral antibiotic suspensions were obtai
ned from 3 major pediatric clinics, and parents were contacted by tele
phone 10 to 14 days after initiation of therapy, at which time informa
tion on age, sex, main disease, prescribed drugs and duration of treat
ment was obtained. Information regarding acceptance, side effects and
compliance was obtained from 11 questions with graded scores. In the s
tudy 546 children received one of the following drugs: amoxicillin (n
= 222); cefaclor (n - 142); cefuroxime axetil (n = 107); trimethoprim/
sulfamethoxazole (n = 75). No major differences in background data wer
e noted; more than 50% of each group had acute otitis media. Seventy-t
hree percent of the cefaclor group reported acceptance of the drug wit
h ''pleasure'' or ''without problems'' vs. 60, 55 and 20% for amoxicil
lin, trimethoprim/sulfamethoxazole and cefuroxime axetil, respectively
, whereas ''resentment'' or ''refusal'' was reported in 11, 16, 26 and
56%, respectively (P < 0.0001). Mothers reported to be generally ''sa
tisfied'' or ''extremely satisfied'' with the drug in 89, 81, 74 and 6
7% with cefaclor, amoxicillin, trimethoprim/sulfamethoxazole and cefur
oxime axetil, respectively, and 85, 77, 73 and 67% of the children, re
spectively, received the drug for the entire prescribed course (P < 0.
001). Our data demonstrate that marked variations exist in acceptance
and compliance of oral antibiotic suspensions with children. These fin
dings should influence the choice of drugs for young pediatric patient
s with common infections.